Science Daily - Heart Disease
JANUARY 8, 2025
People who live close to airports and are exposed to high aircraft noise levels could be at greater risk of poor heart function, increasing the likelihood of heart attacks, life-threatening heart rhythms and strokes, according to a new study.
HCPLive
JANUARY 8, 2025
This Month in Review captures 7 sleep medicine news, including FDA updates, from December 2024.
Medical Xpress - Cardiology
JANUARY 8, 2025
Coach presence on code teams is significantly increased following a quality cardiopulmonary resuscitation (CPR) coach training intervention within a pediatric intensive care unit, according to a study published in the American Journal of Critical Care.
HCPLive
JANUARY 8, 2025
An economic analysis highlights a cardiovascular polypill's potential to lower healthcare costs and address income-based health disparities.
Med Page Today
JANUARY 8, 2025
(MedPage Today) -- Just months after FDA approval, Johnson & Johnson paused the rollout of its Varipulse pulsed field ablation (PFA) platform in the U.S. due to safety reasons. In a U.S. external evaluation cohort, four reported neurovascular.
Medical Xpress - Cardiology
JANUARY 8, 2025
Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland School of Medicine provided an extensive analysis on the second patient in the world to receive a genetically-modified pig organ.
NEJM Journal Watch - Cardiology
JANUARY 8, 2025
In a secondary analysis from a randomized trial, no important differences were noted.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Circulation: Heart Failure
JANUARY 8, 2025
Circulation: Heart Failure, Ahead of Print. BACKGROUND:Patients with end-stage heart failure and low pulmonary capillary wedge pressure are referred to as cold and dry and represent an understudied minority in whom the benefit of left ventricular assist device (LVAD) therapy is unclear.METHODS:Adults receiving LVADs between 2006 and 2017 in the Interagency Registry for Mechanically Assisted Circulatory Support database were classified as cold and wet (pulmonary capillary wedge pressure >1
HeartRhythm
JANUARY 8, 2025
Better risk stratification is needed to evaluate patients with non-ischemic cardiomyopathy (NICM) for prophylactic implantable cardioverter-defibrillators (ICD). Growing evidence suggests cardiac magnetic resonance imaging (CMR) may be useful in this regard.
Medical Xpress - Cardiology
JANUARY 8, 2025
People who live close to airports and are exposed to high aircraft noise levels could be at greater risk of poor heart function, increasing the likelihood of heart attacks, life-threatening heart rhythms and strokes, according to a study led by UCL (University College London) researchers.
Stroke Journal
JANUARY 8, 2025
Stroke, Ahead of Print.
Medical Xpress - Cardiology
JANUARY 8, 2025
Imagine having a digital carbon copy of yourself that physicians could use to predict long-term risks for disease, assess how your body may respond to treatment, and simulate surgeries in advance. A virtual twin may sound as far-fetched as robotic surgery and self-driving cars once did, but researchers are studying how to turn this vision into a reality.
HeartRhythm
JANUARY 8, 2025
Brugada syndrome (BrS) is a genetic heart disease that predisposes individuals to ventricular arrhythmias and sudden cardiac death. Although implantable cardioverter-defibrillators (ICDs) and quinidine are primary treatments, recurrent BrS-triggered ventricular arrhythmias can persist. In this setting, epicardial substrate ablation has emerged as a promising alternative for symptomatic patients.
Medical Xpress - Cardiology
JANUARY 8, 2025
Researchers from Durham University have made an exciting discovery that could improve how doctors treat dangerous heart rhythms, like those seen in cardiac arrest.
CardiacWire
JANUARY 8, 2025
The buzz around artificial intelligences impact on cardiology keeps growing louder, and thats proving to be particularly true in the AI-ECG segment, with 2025 already off to a strong start from ECG startups and researchers alike. AI and ECG pair well due to the strong pattern recognition that machine learning algorithms can achieve. This AI-ECG pairing is bringing the modality into a wider range of diseases and allowing integration with new device form factors.
American College of Cardiology
JANUARY 8, 2025
Transvenous implantable cardioverter-defibrillators (ICDs) are the reference standard for preventing sudden cardiac death (SCD) but have risks associated with intravascular lead placement.
The New England Journal of Medicine
JANUARY 8, 2025
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors.
HCPLive
JANUARY 8, 2025
From 2000 to 2021, primary liver cancer incidences and deaths in the US increased by more than 100%, driven by rapid growth in ALD and MASLD.
The New England Journal of Medicine
JANUARY 8, 2025
In a randomized trial involving patients with severe tricuspid regurgitation, transcatheter tricuspid-valve replacement was superior to medical therapy at 1 year.
HCPLive
JANUARY 8, 2025
Panelists discuss current statistics indicating that COPD is one of the top three leading causes of death worldwide, with high morbidity and mortality rates, particularly in individuals over 40 years of age, and a growing global burden due to risk factors like smoking and air pollution.
Frontiers in Cardiovascular Medicine
JANUARY 8, 2025
BackgroundDepression is being increasingly acknowledged as an important risk factor contributing to coronary heart disease (CHD). Currently, there is no predictive model specifically designed to evaluate the risk of coronary heart disease among individuals with depression. We aim to develop a machine learning (ML) model that will analyze risk factors and forecast the probability of coronary heart disease in individuals suffering from depression.MethodsThis research employed data from the Nationa
HCPLive
JANUARY 8, 2025
Patients in this post-hoc analysis with elevated CRP were found to have a higher BMI and more severe hidradenitis suppurativa.
Cardiometabolic Health Congress
JANUARY 8, 2025
Last month, the 2025 American Diabetes Association (ADA) guidelines were introduced, providing updates for diagnosing and managing diabetes and prediabetes. These new guidelines offer actionable, evidence-based recommendations to improve care delivery. 1. ADA Updates: Continuous Glucose Monitoring (CGM) for Type 2 Diabetes on Glucose-Lowering Agents The ADA now recommends considering CGM for adults with type 2 diabetes who are using glucose-lowering agents other than insulin.
HCPLive
JANUARY 8, 2025
The biosimilars month in review highlights a newly approved ustekinumab biosimilar and a look into the field in 2024.
Becker's Hospital Review - Cardiology
JANUARY 8, 2025
Jose Baez-Escudero, MD, in November stepped into his role as the first systemwide chief of cardiology at Fort Lauderdale, Fla.-based Broward Health, where he also now serves as chief of cardiac electrophysiology.
HCPLive
JANUARY 8, 2025
The designation follows positive topline data from the phase 2a trial of CNP-104 in PBC, which were presented at AASLDs The Liver Meeting
Frontiers in Cardiovascular Medicine
JANUARY 8, 2025
ObjectiveThis meta-analysis aims to evaluate the safety and efficacy of indobufen in the treatment of cardiovascular diseases, cerebrovascular diseases, and thromboembolic disorders. The primary focus is on the incidence of major adverse cardiovascular events (MACE), thrombosis, bleeding events, and adverse reactions. The results are intended to provide a reference for the clinical application of indobufen and suggest directions for further large-scale, multi-center, prospective studies.MethodsT
HCPLive
JANUARY 8, 2025
This analysis using worldwide data from GBD 2021 indicates that the global burden of eczema in children has gradually risen and has been projected to continue increasing.
Frontiers in Cardiovascular Medicine
JANUARY 8, 2025
IntroductionHeart failure (HF) has a very high prevalence in patients with maintenance hemodialysis (MHD). However, there is still a lack of effective and reliable HF diagnostic markers and therapeutic targets for patients with MHD.MethodsIn this study, we analyzed transcriptome profiles of 30 patients with MHD by high-throughput sequencing. Firstly, the differential genes between HF group and control group of patients with MHD were screened.
HCPLive
JANUARY 8, 2025
Phase 2 data demonstrates the effectiveness of LB-102, developed with the potential to be the first-in-class benzamide antipsychotic, for adults with acute schizophrenia.
Frontiers in Cardiovascular Medicine
JANUARY 8, 2025
Background and purposeThe hemoglobin levels in the peripheral blood of individuals living at high altitudes are significantly higher than normal levels. These levels are closely associated with atherosclerosis and cardiovascular events. This study aimed to investigate the correlation between hemoglobin levels in the peripheral blood and hypertension in high-altitude regions, providing a basis for preventing and treating primary hypertension in these regions.Materials and methodsFrom May 2020 to
HCPLive
JANUARY 8, 2025
Panelists discuss how statin therapy can be initiated in children with familial hypercholesterolemia as early as 8 to 10 years old, following careful evaluation and lifestyle interventions.
DAIC
JANUARY 8, 2025
tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. Food and Drug Administration (FDA) has cleared the companys Investigational New Drug (IND) Application for a Phase 2 clinical trial to evaluate the effect of lorundrostat in the treatment of subjects with moderate-to-severe obstructive sleep apne
Society of Thoracic Surgeons - Congenital
JANUARY 8, 2025
News Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs.
HCPLive
JANUARY 8, 2025
Panelists discuss important novel therapies emerging for familial chylomicronemia syndrome (FCS), focusing on APOC3 inhibitors, including small interfering RNA (siRNA) and antisense oligonucleotides (ASO), and their potential to address the underlying lipid metabolism dysfunction in patients with FCS.
Becker's Hospital Review - Cardiology
JANUARY 8, 2025
"Discover the 21 industry leaders being honored by the American College of Cardiology for their contributions to global cardiovascular care and outcomes.
HCPLive
JANUARY 8, 2025
Panelists discuss how lifestyle interventions, including diet, physical activity, and smoking cessation, complement pharmacotherapy in the management of dyslipidemia, and explore unmet needs in cardiovascular risk reduction, highlighting the role of emerging therapies such as bempedoic acid, inclisiran, and gene editing technologies.
Expert insights. Personalized for you.
109 
Let's personalize your content